Combining cellular immunotherapy was an optional choice for unresectable advanced HCC: a systematic review and meta-analysis
Jing Wang(Wenzhou Medical University), Linwei Zhang(Huazhong Agricultural University), Lingxin Feng(Qingdao University)
Cited by 0
Related Papers
Trends in Hospitalization and In-Hospital Mortality From VTE, 2007 to 2016, in China
|CHEST Journal|2018|158
A Wireless Capsule Endoscope System With Low-Power Controlling and Processing ASIC
|IEEE Transactions on Biomedical Circuits and Systems|2009|148
CCNB2 overexpression is a poor prognostic biomarker in Chinese NSCLC patients
|Biomedicine & Pharmacotherapy|2015|126